CHAMPIONS ONCOLOGY, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Champions Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2013 to Q2 2024.
  • Champions Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending July 31, 2024 was 14M shares, a 3.97% increase year-over-year.
  • Champions Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13.5M shares, a 0.05% increase from 2022.
  • Champions Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 13.5M shares, a 4.37% decline from 2021.
  • Champions Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 14.2M shares, a 2.84% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 14M +536K +3.97% May 1, 2024 Jul 31, 2024 10-Q 2024-09-13
Q1 2024 13.5M +6.05K +0.05% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-19
Q4 2023 13.6M +35.1K +0.26% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-15
Q3 2023 13.5M -31.6K -0.23% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-13
Q2 2023 13.5M -15.7K -0.12% May 1, 2023 Jul 31, 2023 10-Q 2024-09-13
Q1 2023 13.5M -618K -4.37% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-19
Q4 2022 13.6M -828K -5.76% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-15
Q3 2022 13.5M -1.02M -7.01% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-13
Q2 2022 13.5M +121K +0.9% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q1 2022 14.2M -414K -2.84% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-24
Q4 2021 14.4M -120K -0.83% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 14.5M -513K -3.41% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-13
Q2 2021 13.4M -830K -5.83% May 1, 2021 Jul 31, 2021 10-Q 2022-09-12
Q1 2021 14.6M +2.73M +23.1% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-22
Q4 2020 14.5M +833K +6.1% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 15.1M +2.1M +16.2% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 14.2M +2.61M +22.5% May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
Q1 2020 11.8M -2.25M -16% Feb 1, 2020 Apr 30, 2020 10-K 2021-07-26
Q4 2019 13.7M +2.17M +18.8% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 13M -1.07M -7.64% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-14
Q2 2019 11.6M -998K -7.91% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 14.1M +3.11M +28.3% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-28
Q4 2018 11.5M +514K +4.67% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 14M +3.05M +27.7% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-16
Q2 2018 12.6M +1.64M +14.9% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 11M Feb 1, 2018 Apr 30, 2018 10-K 2019-07-29
Q4 2017 11M Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 11M Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-17
Q2 2017 11M May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2016 8.7M +2.27M +35.3% Feb 1, 2016 Apr 30, 2016 10-K 2016-07-29
Q4 2015 8.7M +3.1M +55.3% Nov 1, 2015 Jan 31, 2016 10-Q 2016-03-16
Q3 2015 8.7M +3.05M +53.9% Aug 1, 2015 Oct 31, 2015 10-Q 2015-12-15
Q2 2015 8.7M +2.88M +49.5% May 1, 2015 Jul 31, 2015 10-Q 2015-09-11
Q1 2015 6.42M Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 5.6M -61.3M -91.6% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 5.65M -61.2M -91.5% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-15
Q2 2014 5.82M May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q4 2013 66.9M Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 66.9M Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.